This study found that Polybromo‐1 (PBRM1) sensitizes renal cell carcinoma (RCC) to immunotherapy through regulating macrophage‐associated chemokines and increasing M1 macrophage infiltration. This evidence concerns the gene PBRM1 and hereditary clear cell renal cell carcinoma.